OpenBilldrug price receipt

NADAC week of 2026-10-14

ROSUVASTATIN CALCIUM 10 MG TAB

For 30 tablets

Pharmacies pay

$1.08 filed

30 × $0.03602 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$5.62 filed

30 × $0.18719 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

5.2× estimated

Medicare paid 5.2× what pharmacies pay.

Part D averages every strength and form sold under “Rosuvastatin Calcium” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.24 estimated

$1.08 + $0.16 (15%) + $5.00 fee per fill = $6.24

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ROSUVASTATIN CALCIUM 10 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “rosuvastatin calcium” and “rosuvastatin”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, coated”, “tablet” and “tablet, film coated” and its route as oral.

FDA lists 18 labelers (the companies named on the label) for its NDCs, among them AiPing Pharmaceutical, Inc., Torrent Pharmaceuticals Limited and NorthStar RxLLC.

FDA’s Established Pharmacologic Class for it is HMG-CoA Reductase Inhibitor.

The NADAC file of 2026-10-14 prices it under 44 NDCs (National Drug Codes); the FDA directory lists 40 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.08 for 30 tablets (30 × $0.03602 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-10-07. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 18 labelers

LabelerNDCsPharmacies pay per unit
Torrent Pharmaceuticals Limited5$0.03602 per EA filed
AiPing Pharmaceutical, Inc.3$0.03602 per EA filed
Quallent Pharmaceuticals Health LLC3$0.03602 per EA filed
ScieGen Pharmaceuticals, Inc.3$0.03602 per EA filed
Westminster Pharmaceuticals, LLC3$0.03602 per EA filed
American Health Packaging2$0.03602 per EA filed
Ascend Laboratories, LLC2$0.03602 per EA filed
Aurobindo Pharma Limited2$0.03602 per EA filed
Biocon Pharma Inc2$0.03602 per EA filed
Cranbury Pharmaceuticals, LLC2$0.03602 per EA filed
Glenmark Pharmaceutials Inc., USA2$0.03602 per EA filed
NorthStar Rx, LLC2$0.03602 per EA filed
Novadoz Pharmaceuticals LLC2$0.03602 per EA filed
PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS2$0.03602 per EA filed
Rising Pharma Holdings, Inc.2$0.03602 per EA filed
AvPAK1$0.03602 per EA filed
Camber Pharmaceuticals, Inc.1$0.03602 per EA filed
NorthStar RxLLC1$0.03602 per EA filed
Not listed as a package in the FDA directory4$0.03602 per EA filed

When these prices took effect

All 44 NDCs, with labeler and price
  • 11788-0131-05 · AiPing Pharmaceutical, Inc. · $0.03602 per EA · eff. 2026-09-23 filed
  • 11788-0131-10 · AiPing Pharmaceutical, Inc. · $0.03602 per EA · eff. 2026-09-23 filed
  • 11788-0131-90 · AiPing Pharmaceutical, Inc. · $0.03602 per EA · eff. 2026-09-23 filed
  • 13668-0180-05 · Torrent Pharmaceuticals Limited · $0.03602 per EA · eff. 2026-09-23 filed
  • 13668-0180-30 · Torrent Pharmaceuticals Limited · $0.03602 per EA · eff. 2026-09-23 filed
  • 13668-0180-90 · Torrent Pharmaceuticals Limited · $0.03602 per EA · eff. 2026-09-23 filed
  • 13668-0721-05 · TORRENT PHARMACEUTICALS LIMITED · $0.03602 per EA · eff. 2026-09-23 filed
  • 13668-0721-90 · TORRENT PHARMACEUTICALS LIMITED · $0.03602 per EA · eff. 2026-09-23 filed
  • 16714-0989-01 · NorthStar RxLLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 24658-0262-45 · PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS · $0.03602 per EA · eff. 2026-09-23 filed
  • 24658-0262-90 · PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS · $0.03602 per EA · eff. 2026-09-23 filed
  • 27808-0156-01 · Cranbury Pharmaceuticals, LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 27808-0156-03 · Cranbury Pharmaceuticals, LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 31722-0883-90 · Camber Pharmaceuticals, Inc. · $0.03602 per EA · eff. 2026-09-23 filed
  • 43547-0592-09 · not listed as a package in the FDA directory · $0.03602 per EA · eff. 2026-09-23 filed
  • 43547-0592-50 · not listed as a package in the FDA directory · $0.03602 per EA · eff. 2026-09-23 filed
  • 50228-0117-05 · ScieGen Pharmaceuticals, Inc. · $0.03602 per EA · eff. 2026-09-23 filed
  • 50228-0117-10 · ScieGen Pharmaceuticals, Inc. · $0.03602 per EA · eff. 2026-09-23 filed
  • 50228-0117-90 · ScieGen Pharmaceuticals, Inc. · $0.03602 per EA · eff. 2026-09-23 filed
  • 50268-0709-11 · not listed as a package in the FDA directory · $0.03602 per EA · eff. 2026-09-23 filed
  • 50268-0709-15 · AvPAK · $0.03602 per EA · eff. 2026-09-23 filed
  • 57237-0169-90 · Rising Pharma Holdings, Inc. · $0.03602 per EA · eff. 2026-09-23 filed
  • 57237-0169-99 · Rising Pharma Holdings, Inc. · $0.03602 per EA · eff. 2026-09-23 filed
  • 60687-0245-01 · American Health Packaging · $0.03602 per EA · eff. 2026-09-23 filed
  • 60687-0245-11 · not listed as a package in the FDA directory · $0.03602 per EA · eff. 2026-09-23 filed
  • 60687-0245-65 · American Health Packaging · $0.03602 per EA · eff. 2026-09-23 filed
  • 65862-0294-90 · Aurobindo Pharma Limited · $0.03602 per EA · eff. 2026-09-23 filed
  • 65862-0294-99 · Aurobindo Pharma Limited · $0.03602 per EA · eff. 2026-09-23 filed
  • 67877-0440-05 · Ascend Laboratories, LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 67877-0440-90 · Ascend Laboratories, LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 68462-0262-10 · Glenmark Pharmaceutials Inc., USA · $0.03602 per EA · eff. 2026-09-23 filed
  • 68462-0262-90 · Glenmark Pharmaceutials Inc., USA · $0.03602 per EA · eff. 2026-09-23 filed
  • 69367-0360-05 · Westminster Pharmaceuticals, LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 69367-0360-09 · Westminster Pharmaceuticals, LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 69367-0360-10 · Westminster Pharmaceuticals, LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 70377-0007-12 · Biocon Pharma Inc · $0.03602 per EA · eff. 2026-09-23 filed
  • 70377-0007-13 · Biocon Pharma Inc · $0.03602 per EA · eff. 2026-09-23 filed
  • 72205-0003-90 · Novadoz Pharmaceuticals LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 72205-0003-99 · Novadoz Pharmaceuticals LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 72603-0365-01 · NorthStar Rx, LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 72603-0365-02 · NorthStar Rx, LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 82009-0018-10 · Quallent Pharmaceuticals Health LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 82009-0018-90 · Quallent Pharmaceuticals Health LLC · $0.03602 per EA · eff. 2026-09-23 filed
  • 82009-0189-05 · Quallent Pharmaceuticals Health LLC · $0.03602 per EA · eff. 2026-10-07 filed

Other strengths, forms and brands

7 other products in the NADAC file share an FDA nonproprietary name with ROSUVASTATIN CALCIUM 10 MG TAB.

ProductPharmacies pay per unitMedicare per unit
CRESTOR 5 MG TABLET
brand · tablet, film coated
$8.81421 per EA filed
eff. 2026-09-23
$8.79284 per EA filed
Part D 2024 average
CRESTOR 10 MG TABLET
brand · tablet, film coated
$8.8111 per EA filed
eff. 2026-09-23
$8.79284 per EA filed
Part D 2024 average
CRESTOR 20 MG TABLET
brand · tablet, film coated
$8.80624 per EA filed
eff. 2026-09-23
$8.79284 per EA filed
Part D 2024 average
CRESTOR 40 MG TABLET
brand · tablet, film coated
$8.80663 per EA filed
eff. 2026-09-23
$8.79284 per EA filed
Part D 2024 average
ROSUVASTATIN CALCIUM 5 MG TAB
generic · tablet, coated / tablet / tablet, film coated
$0.03215 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.18719 per EA filed
Part D 2024 average
ROSUVASTATIN CALCIUM 10 MG TAB this page
generic · tablet, coated / tablet / tablet, film coated
$0.03602 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.18719 per EA filed
Part D 2024 average
ROSUVASTATIN CALCIUM 20 MG TAB
generic · tablet, coated / tablet / tablet, film coated
$0.04539 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.18719 per EA filed
Part D 2024 average
ROSUVASTATIN CALCIUM 40 MG TAB
generic · tablet, coated / tablet / tablet, film coated
$0.06919 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.18719 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 44 NDCs’ NADAC prices is $0.03602 per EA filed.

Of the 56 other products in FDA’s HMG-CoA Reductase Inhibitor class priced per EA, 50 have a higher middle NADAC price and 6 a lower one. The one in the middle is AMLODIPINE-ATORVAST 10-10 MG, at $0.97947 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $5.62 for 30 tablets, at an average of $0.18719 per EA in 2024 (2024-01-01 to 2024-12-31) for “Rosuvastatin Calcium”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 30,813,501 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ROSUVASTATIN CALCIUM 10 MG TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Rosuvastatin Calcium / Rosuvastatin Calcium: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.